Future of Healthcare

View All Stories

Discovery

Making Possible: Stepping toward a future with cell and gene therapy

Color illustration showing several scientists in front of a large-scale computer highlighting the number 42
Discovery

The data42 program shows Novartis’ intent to go big on data and digital

Achim Plueckebaum, Peter Speyer and Pascal Bouquet of data42
Discovery

Meet Achim, leading the data42 program

Novartis scientist talks to woman on the street.
Discovery

Word on the Street: What is cell and gene therapy?

A Cell Processing Specialist at work in Novartis’ new cell and gene production facility in Stein, Switzerland.
From Our Labs

Hardwiring the future

Investigator leaving a hut in Kenya
Access to Healthcare

Novartis Access impact evaluation: progress update on our work with Boston University

Man wearing AR glasses to manipulate a hologram of a heart
Discovery

Digital health ecosystem gets a boost with the Novartis Biome

Patrice Matchaba is the new Global Head of Corporate Responsibility for Novartis.
Access to Healthcare

Talking to: Patrice Matchaba, Global Head of Corporate Responsibility for Novartis

Narrow photography of a man using a tablet
Patient Perspectives

Digital health: providing opportunities for advocacy groups and a community for patients

Delivering Access: Launching in Kenya
Access to Healthcare

Delivering access: first launch in Kenya